
Surmodics (NASDAQ:SRDX) brought in sales totaling $26.11 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 45.2%, resulting in a loss of $4.08 million. In Q1, Surmodics brought in $23.00 million in sales but lost $2.81 million in earnings.